Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer

被引:32
|
作者
Gemer, O [1 ]
Segal, S [1 ]
Kopmar, A [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr, Dept Obstet & Gynecol, IL-78306 Ashkelon, Israel
关键词
CA; 125; cytoreduction; ovarian cancer;
D O I
10.1034/j.1600-0412.2001.080006583.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Suboptimal cytoreduction of advanced ovarian cancer is related to initial tumor bulk which correlates with CA125 level. Methods. Retrospective record study of 40 patients with stage III ovarian cancer. The ability of a CA125 threshold level of 500 U/mL to predict suboptimal cytoreduction was determined. Results. Twenty-four (60%) of the patients were optimally cytoreduced. At the CA125 cut off level of 500 U/mL the sensitivity for predicting suboptimal debulking was 62% and specificity was 83%. Above a CA 125 level of 1500 U/mL none of the patients were optimally cytoreduced. Conclusions. More data are needed to determine the CA125 cut off level at which the standard approach of initial laparotomy and cytoreduction may be modified.
引用
收藏
页码:583 / 585
页数:3
相关论文
共 50 条
  • [31] CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy
    Pelissier, Aurelie
    Bonneau, Claire
    Chereau, Elisabeth
    Rouge, Thibault de la Motte
    Fourchotte, Virginie
    Dargi, Emile
    Rouzier, Roman
    GYNECOLOGIC ONCOLOGY, 2014, 135 (03) : 542 - 546
  • [32] CA-125 as response criterion in patients with epithelial ovarian cancer
    Zirpel, I
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (04) : 200 - 200
  • [33] CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer
    Memarzadeh, S
    Lee, SB
    Berek, JS
    Farias-Eisner, R
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) : 120 - 124
  • [34] Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review
    Brons, Puck E. E.
    Nieuwenhuyzen-de Boer, Gatske M. M.
    Ramakers, Christian
    Willemsen, Sten
    Kengsakul, Malika
    van Beekhuizen, Heleen J. J.
    CANCERS, 2022, 14 (23)
  • [35] Preoperative abdominopelvic computed tomography and cytoreduction in advanced epithelial ovarian cancer
    Tateo, S
    Morana, S
    Lucchino, S
    La Fianza, A
    Coscia, D
    Dore, R
    7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 311 - 315
  • [36] PREOPERATIVE CANCER ANTIGEN 125 LEVEL AS A PREDICTOR FOR COMPLETE CYTOREDUCTION IN OVARIAN CANCER? A PROSPECTIVE COHORT STUDY AND SYSTEMATIC REVIEW
    Nieuwenhuyzen-De Boer, Gatske
    Brons, Puck
    Ramakers, Christian
    Willemsen, Sten
    Kengsakul, Malika
    Van Beekhuizen, Heleen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A162 - A162
  • [37] Pretreatment CA-125 and risk of relapse in advanced ovarian cancer
    Markmann, M
    Liu, PY
    Rothenberg, ML
    Monk, BJ
    Brady, M
    Alberts, DS
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1454 - 1458
  • [38] PROGNOSTIC VALUE OF CA-125 IN ADVANCED OVARIAN-CANCER
    MOGENSEN, O
    GYNECOLOGIC ONCOLOGY, 1992, 44 (03) : 207 - 212
  • [39] CA-125, A MARKER OF OVARIAN EPITHELIAL TUMORS
    RUIBAL, A
    MEDICINA CLINICA, 1988, 91 (02): : 54 - 57
  • [40] The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery
    Hidayat, Yudi Mulyana
    Winarno, Gatot Nyarumenteng Adhipurnawan
    Tobing, Maringan Diapari Lumban
    Kustiandi, Arieff
    Mantilidewi, Kemala Isnainiasih
    Krisnadi, Sofie Rifayani
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (05) : 739 - 744